LAS VEGAS, Jan. 9, 2024 /PRNewswire/ -- Movano
Health (Nasdaq: MOVE), a pioneer in health technology, and ams
OSRAM, a leader in technology for biometric monitoring, have
collaborated to include ams OSRAMs PPG sensor solution in the Evie
Ring, Movano Health's smart ring designed specifically for
women.
With the goal to bring high-quality data to the forefront of
consumer health devices, Movano Health´s female-first wearable, the
Evie Ring, is a personalized solution designed specifically for
women that provides medical-grade data measurement of critical
vitals for an on-demand understanding of overall health. The Evie
Ring is a 2024 CES Innovation Award Honoree in the Wearables
category.
ams OSRAM´s complete PPG sensor solution, which consists of the
Optical Front End (OFE) SFH 7014c emitter and SFH 2705 detector
technology coupled with the company´s Analog Front End (AFE)
AS7057, is able to achieve an increased total radiant intensity of
more than 40 percent over the previous generation products and
its photodetector has a surface area that is significantly larger
than competing products. This allows for much more sensitive and
accurate readings, overcoming the challenges that all biometric
monitoring devices face: accurate detection of micro modulations of
small light signals, results of scattering and absorption in tissue
and amount of light emitted by LEDs, which strongly affect system
performance. This supports Evie's objective to deliver a device
uniquely built for women's fingers.
"Our world-class engineers have designed the Evie Ring for women
who typically have smaller fingers, and lower perfusion. In order
to ensure a best-in-class experience when it comes to collecting
data from the finger, we needed a cutting edge solution on both the
optical and analog side. The ams OSRAM solution enables us to meet
the unique needs of our consumer," said Michael Leabman, Founder and CTO of Movano
Health. "Ensuring an accurate signal is tantamount to delivering
trusted results and actionable insights."
"Our accurate optical sensors and advanced capabilities of our
analog front end enable a miniaturized yet highly accurate PPG
(Photoplethysmography) system. Through our carefully engineered
technologies, we are able to offer a complete PPG sensor solution
comprised of the industry´s smallest analog front end sensor AS7057
with market leading compact multi-emitter SFH 7014c and SFH 2705
for precise health monitoring. Movano Heath's outstanding design
and the appeal of a female-first solution make them an ideal
partner for revolutionary health monitoring in wearable devices,"
explained Dr. Markus Arzberger,
Senior Director CSA IOS Automotive & Vital Signs (CSA IOS AVS), ams OSRAM.
Movano Health successfully launched the Evie Ring on
November 20, 2023, and showcased the
solution at CES Unveiled this past weekend. The Evie Ring can be
purchased exclusively at www.eviering.com
About Movano Health
Founded in 2018, Movano Inc. (Nasdaq: MOVE) dba Movano Health
is developing a suite of purpose-driven healthcare solutions to
bring medical-grade, high-quality data to the forefront of consumer
health devices. Featuring modern form factors, Movano Health's
devices capture a comprehensive picture of a person's vital health
information and uniquely translate the data into personalized and
intelligent insights that empower consumers to live healthier and
more balanced lives. Movano Health's end-to-end solutions will soon
enable consumers and their healthcare professionals to utilize
daily medical-grade data as a tool to proactively monitor and
manage health outcomes. For more information on Movano
Health, visit https://movanohealth.com/.
Forward Looking Statements
This press release contains
forward-looking statements concerning our expectations,
anticipations, intentions, beliefs, or strategies regarding the
future. These forward-looking statements are based on assumptions
that we have made as of the date hereof and are subject to known
and unknown risks and uncertainties that could cause actual
results, conditions, and events to differ materially from those
anticipated. Therefore, you should not place undue reliance on
forward-looking statements. Examples of forward-looking statements
include, among others, statements we make regarding plans with
respect to commercial launch of the Evie Ring; planned cost-cutting
initiatives; anticipated FDA clearance for the Evie Ring and other
products in development; expected future operating results; product
development and features, product releases, clinical trials and
regulatory initiatives; our strategies, positioning and
expectations for future events or performance. Important factors
that could cause actual results to differ materially from those in
the forward-looking statements are set forth in our most recent
Annual Report on Form 10-K and any subsequent Quarterly Reports on
Form 10-Q, and in our other reports filed with the Securities and
Exchange Commission, including under the caption "Risk
Factors." Any forward-looking statement in this release
speaks only as of the date of this release. We undertake no
obligation to publicly update any forward-looking statement,
whether written or oral, that may be made from time to time,
whether as a result of new information, future developments or
otherwise.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/movano-health-and-ams-osram-collaborate-to-deliver-accurate-lifestyle-monitoring-solutions-for-women-302029285.html
SOURCE Movano